---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-001449"
form_type: "8-K"
ticker: "UTMD"
cik: "0000706698"
company_name: "UTAH MEDICAL PRODUCTS INC"
filed_at: "2023-07-25T23:59:59+00:00"
generated_at: "2026-06-13T03:34:23.178067+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Utah Medical Products reports Q2/H1 2023 results; details not available in filing excerpt

## Summary
- Filing references a press release with financial results for three and six months ended June 30, 2023.
- Specific revenue, EPS, or segment figures are not included in the provided text.
- Forward-looking statements for 2023 and beyond are mentioned but content is unavailable.

## SEC filing metadata
- accession: 0001096906-23-001449
- form_type: 8-K
- ticker: UTMD
- cik: 0000706698
- company_name: UTAH MEDICAL PRODUCTS INC
- filed_at: 2023-07-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 2.02, 9.01, 99.1
- EDGAR index: https://www.sec.gov/Archives/edgar/data/706698/000109690623001449/0001096906-23-001449-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/706698/000109690623001449/utmd-20230725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-001449
- JSON: https://secwatch.observer/filing/0001096906-23-001449.json
- Plain text: https://secwatch.observer/filing/0001096906-23-001449.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.